Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF‐PU.1‐DPP4 Axis. Issue 19 (10th August 2021)
- Record Type:
- Journal Article
- Title:
- Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF‐PU.1‐DPP4 Axis. Issue 19 (10th August 2021)
- Main Title:
- Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF‐PU.1‐DPP4 Axis
- Authors:
- Wang, Lihua
Wang, Ergang
Prado Balcazar, Jorge
Wu, Zhenzhen
Xiang, Kun
Wang, Yi
Huang, Qiang
Negrete, Marcos
Chen, Kai‐Yuan
Li, Wei
Fu, Yujie
Dohlman, Anders
Mines, Robert
Zhang, Liwen
Kobayashi, Yoshihiko
Chen, Tianyi
Shi, Guizhi
Shen, John Paul
Kopetz, Scott
Tata, Purushothama Rao
Moreno, Victor
Gersbach, Charles
Crawford, Gregory
Hsu, David
Huang, Emina
Bu, Pengcheng
Shen, Xiling - Abstract:
- Abstract: Colorectal cancer (CRC) metastasizes mainly to the liver, which accounts for the majority of CRC‐related deaths. Here it is shown that metastatic cells undergo specific chromatin remodeling in the liver. Hepatic growth factor (HGF) induces phosphorylation of PU.1, a pioneer factor, which in turn binds and opens chromatin regions of downstream effector genes. PU.1 increases histone acetylation at the DPP4 locus. Precise epigenetic silencing by CRISPR/dCas9 KRAB or CRISPR/dCas9 HDAC revealed that individual PU.1‐remodeled regulatory elements collectively modulate DPP4 expression and liver metastasis growth. Genetic silencing or pharmacological inhibition of each factor along this chromatin remodeling axis strongly suppressed liver metastasis. Therefore, microenvironment‐induced epimutation is an important mechanism for metastatic tumor cells to grow in their new niche. This study presents a potential strategy to target chromatin remodeling in metastatic cancer and the promise of repurposing drugs to treat metastasis. Abstract : Metastasis of colorectal cancer to the liver is a leading cause of cancer‐related death. This work shows that metastatic colorectal cancer cells undergo chromatin remodeling in the liver via an HGF‐PU.1‐DPP4 axis. Pharmacological or genetic inhibition of this remodeling axis can suppress liver metastasis and prolong survival.
- Is Part Of:
- Advanced science. Volume 8:Issue 19(2021)
- Journal:
- Advanced science
- Issue:
- Volume 8:Issue 19(2021)
- Issue Display:
- Volume 8, Issue 19 (2021)
- Year:
- 2021
- Volume:
- 8
- Issue:
- 19
- Issue Sort Value:
- 2021-0008-0019-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-08-10
- Subjects:
- chromatin remodeling -- colorectal cancer -- DPP4 -- epigenetics -- hepatic growth factor (HGF) -- metastasis -- PU.1
Science -- Periodicals
505 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2198-3844 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/advs.202004673 ↗
- Languages:
- English
- ISSNs:
- 2198-3844
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26880.xml